BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 917 filers reported holding BAXTER INTL INC in Q4 2013. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $185,000 | -43.4% | 3,569 | -51.5% | 0.30% | -11.9% |
Q4 2016 | $327,000 | -2.1% | 7,365 | +5.1% | 0.34% | -0.9% |
Q3 2016 | $334,000 | +0.3% | 7,008 | -4.7% | 0.35% | 0.0% |
Q2 2016 | $333,000 | +5.0% | 7,355 | -4.7% | 0.35% | +12.3% |
Q1 2016 | $317,000 | +4.6% | 7,715 | -2.9% | 0.31% | +6.2% |
Q4 2015 | $303,000 | +1.0% | 7,945 | -13.0% | 0.29% | +7.8% |
Q3 2015 | $300,000 | -72.1% | 9,135 | -40.5% | 0.27% | -62.6% |
Q2 2015 | $1,074,000 | +8.9% | 15,352 | +6.6% | 0.72% | +16.3% |
Q1 2015 | $986,000 | +16.3% | 14,397 | +24.4% | 0.62% | +5.4% |
Q4 2014 | $848,000 | +41.6% | 11,577 | +38.8% | 0.59% | +41.3% |
Q3 2014 | $599,000 | +7.3% | 8,342 | +8.1% | 0.42% | +8.6% |
Q2 2014 | $558,000 | +862.1% | 7,717 | +880.6% | 0.38% | +834.1% |
Q1 2014 | $58,000 | +5.5% | 787 | 0.0% | 0.04% | +10.8% |
Q4 2013 | $55,000 | – | 787 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |